UC student research targets tick-borne illness
Nigerian student works to address Lyme disease
The Guardian highlighted student biology research that is pursuing pesticide-free ways of preventing tick-borne illness.
A dog tick in a UC biology lab. UC is studying ways to address tick-borne illness. Photo/Jay Yocis/UC
In UC College of Arts and Sciences Professor Joshua Benoit's lab, doctoral student Kosisochukwu Onyeagba is studying how to exploit a tick's ability to sense humidity to kill them. Ticks use a specialized organ to find refuge to survive dry conditions.
But if researchers find a way to disrupt the organ, the tick will die from dehydration.
“The idea is to outsmart them, not just eliminate them,” Onyeagba told the Guardian. “We’re targeting behavior, not biology. No toxicity. No resistance.”
Nearly a half-million people in the United States contract Lyme disease each year, according to the Centers for Disease Control and Prevention. The disease is most prevalent in the Northeast but it has been reported in all 50 states.
Onyeagba was a co-author on a study published in BioRxix, a pre-print server that allows researchers to share results and solicit feedback before pursuing publication in a peer-reviewed journal.
Featured image at top: UC biology students are studying ways to prevent tick-borne illness. Photo/Joseph Fuqua II/UC
Related Stories
Can ChatGPT help holiday shoppers?
December 5, 2025
Holiday shopping can be difficult. That’s why WLWT turned to Lindner College of Business professor Sachin Modi for insights on if large language models like ChatGPT can be helpful in finding more tailored gifts for loved ones.
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.